Skip to Main Content

Paper Details

TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
Clin Cancer Res
80
2008
ADAM-17, CRC, CRC tumors, EGFR, EGFR ligands, EGFR monoclonal antibody, EGFR tyrosine kinase, EGFR tyrosine kinase-resistant clone, HCA-7, HCA-7 cells, TACE, TGF-alpha, Transforming growth factor-alpha, amphiregulin, colorectal cancer, disintegrin and metalloprotease, epidermal growth factor receptor, human, human polarizing colorectal cancer (CRC) cell line, mitogen-activated protein kinase, polarized HCA-7 cells, polarized epithelial cells, tumor necrosis factor-alpha converting enzyme, tyrosine

Datasets